Oncogene-induced senescence is an important barrier during melanomagenesis. In this issue of Cancer Cell, Yu et al. show how elevated expression of structurally unrelated H3K9 demethylases disables senescence and constitutes a liability that can be exploited to restore senescence in melanoma by pharmacological inhibition of these epigenetic regulators
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Background: Oncogene-induced senescence is considered to act as a potent barrier to cell transformat...
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle...
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is thought to be a barrier to malignant transformation resulting f...
International audienceCutaneous melanoma is a deadly skin cancer that originates from melanocytes. T...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Oncogene-induced senescence, e.g., in melanocytic nevi, terminates the expansion of pre-malignant ce...
Background: Oncogene-induced senescence is considered to act as a potent barrier to cell transformat...
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle...
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is a well-documented phenomenon both in vitro and in vivo as a tum...
Oncogene-induced senescence (OIS) is thought to be a barrier to malignant transformation resulting f...
International audienceCutaneous melanoma is a deadly skin cancer that originates from melanocytes. T...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...
International audienceNormal cells possess a limited proliferative life span, after which they enter...